SORCS3 and cancer: To further verify that the biological function of SorCS3 in suppressing cancer is achieved through the NGF/p75NTR signalling pathway, we selected the competitive NGF inhibitor Ro 08-2750 to inhibit binding between endogenous NGF and p75NTR.